| IPF | Idiopathic pulmonary fibrosis |
| COPD | Chronic obstructive pulmonary disease |
| AA | Allergic asthma |
| M | Million |
| ECM | Extracellular matrix |
| EMT | Epithelial–mesenchymal transition |
| ADI | Alveolar differentiation intermediate |
| FN | Fibronectin |
| LOX | Lysyl oxidase |
| MUC | Mucin |
| MMAD | Mass median aerodynamic diameter |
| LAM | Laminin |
| COL | Collagen |
| TNC | Tenascin C |
| VCAN | Versican |
| FVC | Forced vital capacity |
| BET | Bromodomain and extra-terminal domain |
| BRD | Bromodomain-containing protein |
| BD | Bromodomain |
| CTGF | Connective tissue growth factor |
| TGF-β | Transforming growth factor-beta |
| LOXL | Lysyl oxidase-like |
| PET | Positron emission tomography |
| PEG | Poly(ethylene glycol) |
| pSar | Polysarcosine |
| siRNA | Small interfering RNA |
| mRNA | Messenger RNA |
| LNP | Lipid nanoparticle |
| PAMAM | Poly(amidoamine) |
| PLGA | Poly(lactic-co-glycolic acid) |
| KRAS | Kristen rat sarcoma viral oncogene |
| DPC | Dendrimer–peptide conjugate |
| FF | Fibroblastic foci |
| MMP | Metalloproteinases |